Discover and read the best of Twitter Threads about #courtingcontroversy
Most recents (1)
Thanks to all my colleagues for voting. This is an interesting question in breast oncology, and practice varies quite a bit (As you can see from the poll)
#medtwitter #breastcancer #OncoAlert #chemo #courtingcontroversy
#oncology
#tweetorial
Thread
1/6
#medtwitter #breastcancer #OncoAlert #chemo #courtingcontroversy
#oncology
#tweetorial
Thread
1/6
There is interest in getting rid of anthracyclines from adjuvant chemotherapy of breast cancer, due to long-term concerns of heart failure and secondary leukemia. The ABC meta-analysis seemed to concur that taxane+anthracycline (TaxAC) beats 6TC by a small margin
2/6
2/6
An unplanned subgroup analysis revealed interaction with number of nodes in HR+ patients, with no benefit in HR+ N0 disease.
3/6
3/6
